Parathyroid cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Parathyroid cancer must be differentiated from renal disease, immobility, and | Parathyroid cancer must be differentiated from [[renal disease]], [[immobility]], and granulomatous diseases. | ||
==Differentiating Parathyroid cancer from other Diseases== | ==Differentiating Parathyroid cancer from other Diseases== | ||
* Granulomatous disease (tuberculosis, sarcoidosis) | * Granulomatous disease ([[tuberculosis]], [[sarcoidosis]]) | ||
* Renal disease | * Renal disease | ||
* Immobility | * [[Immobility]] | ||
* Malignancy (esp. squamous cell carcinoma, plasmacytoma) | * [[Malignancy]] (esp. [[squamous cell carcinoma]], [[plasmacytoma]]) | ||
* Endocrine (primary hyperparathyroidism, tertiary hyperparathyroidism, familial hypocalciuric hypercalcemia (FHH)). | * Endocrine ([[primary hyperparathyroidism]], [[tertiary hyperparathyroidism]], familial hypocalciuric hypercalcemia (FHH)). | ||
* Drugs (thiazides) | * Drugs ([[thiazides]]) | ||
==Reference== | ==Reference== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:10, 29 December 2015
|
Parathyroid cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parathyroid cancer differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Parathyroid cancer differential diagnosis |
|
Risk calculators and risk factors for Parathyroid cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Parathyroid cancer must be differentiated from renal disease, immobility, and granulomatous diseases.
Differentiating Parathyroid cancer from other Diseases
- Granulomatous disease (tuberculosis, sarcoidosis)
- Renal disease
- Immobility
- Malignancy (esp. squamous cell carcinoma, plasmacytoma)
- Endocrine (primary hyperparathyroidism, tertiary hyperparathyroidism, familial hypocalciuric hypercalcemia (FHH)).
- Drugs (thiazides)